Hjem › Interstitielle lungesykdommer › Colorado
Kliniske studier for Interstitielle lungesykdommer i Colorado
15 studier for Interstitielle lungesykdommer søker deltakere på steder i Colorado.
Byer i Colorado
Offisiell studietekst (engelsk)
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of Colorado Denver, Aurora
RekruttererFase 3
Alder 40 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07201922LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Colorado, Denver
- National Jewish Hospital, Denver
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT05798923A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Aurora
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- National Jewish Health, Denver
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- National Jewish Health, Denver
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- University of Colorado Hospital, Aurora
- National Jewish Hospital, Denver
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07285655DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Colorado - Anschutz Medical Campus, Aurora
- National Jewish Health, Denver
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 26. aug. 2026 · NCT06388421PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- University of Colorado | Anschutz Medical Campus, Aurora
RekruttererObservasjonsstudie
Alder 18 til 80 · Alle kjønn · Oppdatert 18. aug. 2026 · NCT06855329Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Colorado, Aurora
RekruttererObservasjonsstudie
Alder 21 og eldre · Alle kjønn · Oppdatert 12. aug. 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- University of Colorado, Aurora
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07175038An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- National Jewish Health, Denver
RekruttererObservasjonsstudie
Alder 18 til 80 · Alle kjønn · Oppdatert 26. jun. 2026 · NCT06129240A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
- GSK Investigational Site, Aurora
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 65 · Alle kjønn · Oppdatert 22. jun. 2026 · NCT06576271TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Children's Hospital Colorado, Aurora
RekruttererObservasjonsstudie
Opp til 24 år · Alle kjønn · Oppdatert 22. jun. 2026 · NCT04098445Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease
- University of Colorado - Anschutz Medical Campus, Aurora
RekruttererObservasjonsstudie
Alder 45 til 90 · Alle kjønn · Oppdatert 1. mai 2026 · NCT03297775Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
- University of Colorado Denver, Aurora
RekruttererObservasjonsstudie
Alder 18 til 90 · Alle kjønn · Oppdatert 3. mai 2024 · NCT06397677Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.